Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc (BDRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BDRX · as of Jun 8, 2026
Key Statistics
Explore Biodexa Pharmaceuticals Plc Data
bdrx stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bdrx competitorsBDRX
BIVI
CANF
CNSP
ESLA
GLMDStock Performance
Full HistoryAbout Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder c…
what is biodexa pharmaceuticals plc · bdrx stock overview · biodexa pharmaceuticals plc company profile · who is biodexa pharmaceuticals plc ceo · bdrx NASDAQ · biodexa pharmaceuticals plc headquarters · biodexa pharmaceuticals plc business segments
About Stock Overview & Key Data
Biodexa Pharmaceuticals Plc (BDRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 7, 2015. As of the latest trading session, BDRX stock price is $3.37, with a market capitalization of $565,341. The stock has returned -94.15% over the past 12 months and -70.34% year-to-date.
In fiscal year 2025, Biodexa Pharmaceuticals Plc reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biodexa Pharmaceuticals Plc (BDRX) stock price is $3.37. The stock is traded on NASDAQ under the ticker symbol BDRX. The 52-week range is $2.86 – $66.50.